Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Chiracon GmbH logo — Von der Struktur zum Wirkstoff From Structure to Drug Subst...

Chiracon GmbH

Von der Struktur zum Wirkstoff From Structure to Drug Substance

Founded 1998 9 employees Series Unknown Biotechnology, Health Care +1

General Information

Company Name Chiracon GmbH
Founded Year 1998
Employees 9
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when Chiracon GmbH moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Chiracon GmbH

Chiracon GmbH is a German-based company with a slogan "Von der Struktur zum Wirkstoff" which translates to "From Structure to Drug Substance." Founded in 1998, the company has accrued 20 years of expertise in drug synthesis and documentation within the Biotechnology, Health Care, and Pharmaceutical industries. Specializing in organic synthesis, scale-up, and production, Chiracon GmbH offers services for synthetic drug development, catering to both new and generic products. Their comprehensive offerings encompass the provision of all necessary documentation for active pharmaceutical ingredients (APIs) for clinical trials, as well as for the introduction of new APIs to market through ASMF (active substance master files) / DMF (drug master files), Pharmaceutical Quality / CMC (Chemistry, Manufacturing, and Controls) / IMPD (Investigational Medicinal Product Dossier). The company operates within an integrated ISO9001 system, incorporating a GMP environment to ensure quality management. Chiracon GmbH received a Venture Round investment on 01 April 2005 from Triginta Capital. The infusion of capital from Triginta Capital signifies external validation of the company's potential, bolstering its position within the market.

Taxonomy: Drug synthesis, Organic synthesis, Scale up, APIs, Active pharmaceutical ingredients, Clinical trials, ASMF, DMF, Pharmaceutical Quality, CMC, IMPD, ISO9001, GMP environment, Berlin-Brandenburg, Chiracon GmbH

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1 •••• •••• 01 Apr 2005

Chiracon GmbH Alternatives & Competitors

Chiracon GmbH vs
Inke
Inke Spain

Inspiring Sustainable Solutions for Global Health

99 employees
Manufacturing, Medical Devices
Chiracon GmbH vs
Purisys
Purisys United States

Supporting Pharma and Biotech Companies with Commercial CDMO Services, Reference Standards and Contr...

28 employees
Information Technology, Manufacturing
Chiracon GmbH vs
Bioquim S.A.
Bioquim S.A. Spain

European GMP-certified company manufacturing bulk APIs, specializing in sterile lyophilization and c...

41 employees
Manufacturing, Pharmaceutical

FAQ About Chiracon GmbH

Von der Struktur zum Wirkstoff From Structure to Drug Substance
Chiracon GmbH was founded in 1998.
Chiracon GmbH operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Chiracon GmbH has approximately 9 employees.
Chiracon GmbH has completed 1 funding round. The latest funding stage is Series Unknown.
Top alternatives and competitors to Chiracon GmbH include Inke, Purisys, Bioquim S.A., American Custom Chemicals Corporation, Olon. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Chiracon GmbH and Inke are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Chiracon GmbH and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy